Ordenar

Buscar

01/05/2026 Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI)
Albert, A, Blume, L, Di Somma, S, Hur, M, Bellomo, R, Devarajan, P, Breidthardt, T, Camou, F, Chocron, S, Cruz, D, de Geus, HR, Doi, K, Endre, ZH, Garcia-Alvarez, M, Haase, M, Haase-Fielitz, A, Hjortrup, PB, Karaolanis, G, Kavalci, C, Kim, H, Lange, S, Lauten, P, Lentini, P, Liebetrau, C, Lipcsey, M, Mårtensson, J, Müller, C, Nanas, S, Nickolas, TL, Pickering, JW, Pipili, C, Ronco, C, Rosa-Diez, G, Ralib, AM, Soto, K, Stieger, P, Zapf, A, Braun-Dullaeus, RC, Albert, C. Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI). Kidney Medicine. 2026; 8(5)DOI:10.1016/j.xkme.2026.101280. PMID:41953143. IF:(Q/D).
01/05/2026 A freeze-dried platelet-derived hemostatic agent improves hemostasis in patients with severe thrombocytopenia before and after standard platelet transfusion: Studies ex vivo in the total thrombus-formation analysis system 01
Samanbar, S, Piñeyroa, JA, Moreno-Castaño, AB, Molina, P, Pino, M, Torramade-Moix, S, Martinez-Sanchez, J, Moskowitz, K, Koller, T, Lozano, M, Escolar, G, Diaz-Ricart, M. A freeze-dried platelet-derived hemostatic agent improves hemostasis in patients with severe thrombocytopenia before and after standard platelet transfusion: Studies ex vivo in the total thrombus-formation analysis system 01. TRANSFUSION. 2026; 66(5)DOI:10.1111/trf.70153. PMID:41788007. IF:2.000(Q3/6D).
01/05/2026 Evaluation of grading of recommendations assessment, development, and evaluation approach adherence in clinical practice guidelines: a systematic survey of criteria and their applications
Yan, SY, Guyatt, GH, Ren, XY, Alonso-Coello, P, Dahm, P, Huang, Q, Wang, YB, Jin, YH, Yao, XM. Evaluation of grading of recommendations assessment, development, and evaluation approach adherence in clinical practice guidelines: a systematic survey of criteria and their applications. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 193DOI:10.1016/j.jclinepi.2026.112186. PMID:41722827. IF:5.200(Q1/1D).
01/05/2026 Biological therapy for chronic obstructive pulmonary disease (COPD): Effectiveness and safety
Morales, OMG, Diaz, L, Auladell-Rispau, A, Poloni, D, Torres-López, LA, Cuchi, GU, Rojas-Reyes, MX. Biological therapy for chronic obstructive pulmonary disease (COPD): Effectiveness and safety. RESPIRATORY MEDICINE. 2026; 256DOI:10.1016/j.rmed.2026.108815. PMID:41974360. IF:3.100(Q2/4D).
01/05/2026 Vascular age: a tool to facilitate communication with patients about cardiovascular risk
Brotons, C, Moral, I. Vascular age: a tool to facilitate communication with patients about cardiovascular risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500936. PMID:41991403. IF:(Q/D).
01/05/2026 Growth Hormone Therapy in 5q35 Duplication Syndrome: Evidence From a Long-Term Follow-Up
Cáceres, A, Carreras, G, Pérez-Jurado, LA. Growth Hormone Therapy in 5q35 Duplication Syndrome: Evidence From a Long-Term Follow-Up. CLINICAL ENDOCRINOLOGY. 2026; 104(5)DOI:10.1111/cen.70089. PMID:41473979. IF:2.400(Q3/7D).
01/05/2026 Transcystic approach in the management of choledocholithiasis: intraoperative complications and technical considerations
Arnau, ABM, Jose, LEGS, Santos, VM, Sánchez-Cabús, S. Transcystic approach in the management of choledocholithiasis: intraoperative complications and technical considerations. CIRUGIA ESPANOLA. 2026; 104(5)DOI:10.1016/j.ciresp.2026.800312. PMID:. IF:1.300(Q3/7D).
01/05/2026 Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome
Alijotas-Reig, J, Esteve-Valverde, E, Sáez-Comet, L, Anunciación-Llunell, A, Ferrer-Oliveras, R, Lefkou, E, Mekinian, A, Belizna, C, Hoxha, A, Tincani, A, Marozio, L, Espinosa, G, de Carolis, S, Udry, S, Latino, JO, Llurba, E, Chighizola, CB, Gerosa, M, Pengo, V, Lundelin, K, Rovere-Querini, P, Canti, V, Mayer-Pickel, K, Reshetnyak, T, Tabacco, S, Stojanovich, L, Gonçalves, BA, Morales-Perez, S, Miró-Mur, F. Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2026; 321DOI:10.1016/j.ejogrb.2026.115055. PMID:41797084. IF:1.900(Q2/5D).